Search for: "Bill Bayer" Results 81 - 100 of 264
Sorted by Relevance | Sort by Date
RSS Subscribe: 20 results | 100 results
2 Oct 2009, 12:55 pm
Eight states adopted similar bills: Delaware, Montana, Nevada, Oregon, Wyoming, New Mexico and Florida. [read post]
22 Aug 2016, 12:53 pm by Tom Lamb
“Because AndexXa addresses an urgent unmet medical need, we and the FDA are committed to resolving the outstanding questions to determine the appropriate next steps,” Bill Lis, CEO of Portola, said in the release. [read post]
29 Aug 2013, 4:24 am by Andrew Trask
Bayer Corp. leaves defendants vulnerable to serial re-litigation of the same class action. [read post]
23 Dec 2020, 6:11 am by Magdaleen Jooste
Kluwer Trademark Blog reported on the case of Bayer v Richter/Exeltis which seems to change this understanding. [read post]
13 Feb 2014, 11:10 am
Bayer AG Corp. [2012 WL 1019824 (S.D. [read post]
11 Mar 2011, 5:00 am by Holly Hayes
 For details, see Disputing‘s post on the Texas bill here. [read post]
13 Sep 2012, 2:03 pm by Abhinav Chandrachud
(5) Examine the impact of the judgment in Natco v Bayer and its significance for developing countries in the field of compulsory licensing.The committee also organizes the Belles-Lettres J.E. [read post]
25 Oct 2011, 9:28 am by Jenna Greene
Court of Appeals for the 2nd Circuit that found a pay for delay deal between Bayer AG and Barr Pharmaceuticals (now owned by Teva Pharmaceuticals) to drop a patent lawsuit over the antibiotic Cipro did not violate antitrust laws. [read post]
29 Nov 2023, 5:00 am by Vincent Joralemon
Again, psychedelic therapies aren’t cheap, so this is a good thing.The post Ketamine is the New Viagra first appeared on Bill of Health.The post Ketamine is the New Viagra appeared first on Bill of Health. [read post]
11 Feb 2016, 2:25 pm by Altman & Altman
You may be entitled to compensation for medical bills, pain and suffering, and lost wages. [read post]
20 Oct 2009, 6:57 am
We are helping women receive compensation for their medical bills, as well as pain and suffering. [read post]
26 Aug 2009, 6:12 am
(Korea IP Law Blog) US: Senate Agriculture/FDA Appropriations Bill amendment seeks to streamline development and regulation of products for rare and neglected diseases (FDA Law Blog) US: Professor Grabowski’s economic analysis of data exclusivity for follow-on biologic drugs (Patent Docs) US: Follow-on biologics news briefs: President Obama wants to speed up introduction of generic drugs; biosimilars pose ‘limited threat’; Amgen CEO says biologic manufacturers… [read post]
6 Oct 2010, 4:22 am by Kelly
(profitability through simplicity) US: Yeda Appeals Board decision favoring Abbott in TBP-II interference (Holman’s Biotech IP Blog) US: Jury finds Scruggs wilfully infringed Monsanto patents, awards at least $9 million in damages (Holman’s Biotech IP Blog) US: Marcy Kaptur’s bill to create a compulsory license for patented seeds: the Seed Availability and Competition Act of 2009 (KEI) US: Glaxosmithkline Biologicals seeks review of BPAI decision concerning isolated… [read post]
20 Oct 2009, 6:57 am
We are helping women receive compensation for their medical bills, as well as pain and suffering. [read post]
28 Sep 2011, 1:56 am by Marie Louise
Bowman (Patent Docs) (IPBiz) (Patently-O) Australia: Divided Senate Committee urges rejection of Gene Patents Bill (Patentology) (BIOtechNOW) (ipwars.com) (IP Whiteboard)   Please join the discussion by adding your comments on any of these stories, and please do let us know if you think we’ve missed something important, or if there is a source you think should be monitored. [read post]
13 Feb 2009, 5:00 am
(Profitability through Simplicity) Patent World SPC round-up ‘Prolonging Patent Protection’ by Marjan Noor (SPC Blog) EU: Commission’s view on paediatric extensions (The SPC Blog) EU: Suing, not suing both attract the Commission’s attention – EU pharma inquiry (PatLit) EU: Life Science marks held confusingly similar: Bayern Innovativ – Bayerische Gesellschaft für Innovation und Wissenstransfer mbH, v Office for Harmonisation in the… [read post]
29 Sep 2009, 7:21 am
Key elements of the marketing strategy of these pills are what could be billed as peripheral benefits. [read post]
29 Sep 2009, 7:21 am
Key elements of the marketing strategy of these pills are what could be billed as peripheral benefits. [read post]